AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇦

Fluticasone Furoate in South Africa

9 products registered with SAHPRA 9 active

Brand / ProductReg. No.HolderStatusExpires
FURAMIST57/21.5.1/0163Cipla Medpro (Pty) Ltdactive12 Nov 2029
ELEBRATO ELLIPTA52/21.5.1/0178GlaxoSmithKline South Africa (Pty) Limitedactive6 Jan 2026
GENEMIST41/21.5.1/0967GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900
REVINTY ELIPTA 184/22 ug48/21.5.1/0248GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900
RELVAR ELIPTA 184/22 ug48/21.5.1/0250GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900
RELVAR ELIPTA 92/22 ug48/21.5.1/249GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900
TRELEGY ELLIPTA52/21.5.1/0177GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900
REVINTY ELIPTA 92/22 ug48/21.5.1/0247GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900
AVAMYS41/21.5.1/0968GlaxoSmithKline South Africa (Pty) Limitedactive1 Jan 1900

Fluticasone FuroateSAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Fluticasone Furoate, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Fluticasone Furoate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.